ÂÜÀòÂÒÂ×

Dr. Kilpatrick obtained his PhD in Chemistry in 1981 from the University of Birmingham, UK for his studies on the ribonucleic acid of mycoplasma. Following periods as a postdoctoral research fellow at the University of Winsconsin-Madison, the University of Alabama at Birmingham and the Imperial Cancer Research Fund laboratories in London, he joined the faculty of the University of Birmingham as the Wellcome Trust Lecturer in Molecular Genetics, where he was responsible for the introduction of a molecular program for the study of human genetic disease. Subsequently, Dr. Kilpatrick joined the faculty of the University of Connecticut Health Center where his collaborations with Dr. Tsipouras and Dr. Tafas began. Dr. Kilpatrick has more than 100 scientific publications in the fields of nucleic acid structure and function and human molecular genetics, and has served on NIH study sections. His research has been funded by the Medical Research Council, the Wellcome Trust, NATO, the Arthritis and Rheumatism Council and the NIH.